Edition:
India

John Miller

Jeff Mason is a White House Correspondent for Reuters and the 2016-2017 president of the White House Correspondents’ Association. He was the lead Reuters correspondent for President Barack Obama's 2012 campaign and interviewed the president at the White House in 2015. Jeff has been based in Washington since 2008, when he covered the historic race between Obama, Hillary Clinton and John McCain. Jeff started his career in Frankfurt, Germany, where he covered the airline industry before moving to Brussels, Belgium, where he covered the European Union. He is a Colorado native, proud graduate of Northwestern University and former Fulbright scholar.

Twitter handle: @jeffmason1

5:41pm IST

Credit Suisse to fight on after setback in Lake Las Vegas resort case

ZURICH Credit Suisse said on Friday it would fight on after a Texas appeals court upheld a $351 million award against the Swiss bank over its role in a Las Vegas resort project whose finances collapsed a decade ago.

21 Feb 2018

Spanish Supreme Court orders arrest of former Catalan MP Anna Gabriel

MADRID/ZURICH Spain's Supreme Court ordered the arrest of former Catalan member of parliament Anna Gabriel after she failed to appear in court on Wednesday to answer charges related to the region's independence campaign.

21 Feb 2018

Spanish Supreme Court orders arrest of former Catalan MP Anna Gabriel

MADRID/ZURICH Spain's Supreme Court ordered the arrest of former Catalan member of parliament Anna Gabriel after she failed to appear in court on Wednesday to answer charges related to the region's independence push.

21 Feb 2018

Watchdog probes Swiss banks over links to Venezuela graft case

ZURICH Swiss financial watchdog FINMA said on Wednesday it is investigating several Swiss banks over whether they followed anti-money laundering rules amid a widening $1 billion graft probe involving Venezuela's state oil company.

13 Feb 2018

Novartis gains U.S. approval for delayed MS drug

ZURICH Novartis's Sandoz division has won U.S. approval for a larger dosage of its Glatopa drug for multiple sclerosis (MS) patients, ending a costly delay that allowed rival generics makers to beat it to market.

12 Feb 2018

Greek PM wants politicians investigated in alleged Novartis bribery case

ATHENS/ZURICH Greece's prime minister urged parliament on Monday to probe politicians in an alleged drug bribery case, while Swiss drugmaker Novartis promised to take action if an investigation found unethical conduct.

09 Feb 2018

Roche wins UK watchdog's nod for lymphoma drug after initial snub

ZURICH Britain's healthcare watchdog (NICE) recommended Roche's medicine Gazyvaro for previously untreated advanced follicular lymphoma patients after initially rejecting the Swiss drugmaker's medicine last year as too expensive.

07 Feb 2018

In Switzerland, dismay as papers on secret Cold War army vanish

ZURICH A covert Swiss Cold War paramilitary group that operated largely outside civilian oversight until 1990 is back in the news after top-secret documents linked to the organisation vanished from official archives.

06 Feb 2018

Roche notches fresh win amid crowd of immunotherapy cocktails

ZURICH Roche's Tecentriq mixed with an older drug cut the risk of death in kidney cancer, marking another win for the Swiss drugmaker's immuno-oncology (I/O) cocktail as it battles better-established medicines made by its rivals.

01 Feb 2018

Roche says rising biosimilar threat will speed up Rituxan sales fall

ZURICH Swiss drugmaker Roche expects erosion of Rituxan sales in Europe will intensify in 2018 as cheaper copies made by rivals gather momentum, its drug unit said on Thursday.

Markets

  • Asia
  • U.S.
  • Europe
  • Sectors
Stock Search
Sensex 34,142.15 + 322.65 +0.95%
Nikkei 21,892.78 + 156.34 +0.72%
Hang Seng 31,267.17 + 301.49 +0.97%
EUR/INR 79.642 -0.57%
USD/INR 64.710 -0.40%
GBP/INR 90.469 -0.25%
Gold 1,330.10 -0.50 -0.04%
Oil 63.30 +0.53 +0.84%
Corn 365.50 -1.25 -0.34%